| 1 |
A study on tuberculosis disease disclosure patterns and its associated factors: Findings from a prospective observational study in Chennai |
|
|
| Karikalan Nagarajan, Malaisamy Muniyandi, Senthil Sellappan, Srimathi Karunanidhi, Keerthana Senthilkumar, Bharathidasan Palani, Lavanya Jeyabal, Rajendran Krishnan, Jayanta Kumar Bora |
|
| PLOS ONE. 2023; 18(1): e0280812 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Impact and cost-effectiveness evaluation of nutritional supplementation and complementary interventions for tuberculosis treatment outcomes under mukti pay-for-performance model in Madhya Pradesh, India: A study protocol |
|
|
| Shankar Prinja, Atul Sharma, Sudheer Nadipally, SarojKumar Rana, Pankaj Bahuguna, Neeta Rao, Gautam Chakraborty, Manjunath Shankar, Varsha Rai |
|
| International Journal of Mycobacteriology. 2023; 12(1): 82 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Computational design of MmpL3 inhibitors for tuberculosis therapy |
|
|
| R. Chaitra, Rohit Gandhi, N. Jayanna, Sachin Satyanath, Parasuraman Pavadai, Manikanta Murahari |
|
| Molecular Diversity. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Ophelia syndrome followed by tubercular meningitis in a patient with relapsed Hodgkin lymphoma, could MR imaging have saved his life? |
|
|
| Sharath Kumar Goddu Govindappa, Chaitra Parameshwara Adiga, Vaishnavi Srinarahari, Sujit kumar |
|
| Acta Neurologica Belgica. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Time trends in tuberculosis mortality across the BRICS: an age-period-cohort analysis for the GBD 2019 |
|
|
| Zhiyong Zou, Guangqi Liu, Simon I. Hay, Saurav Basu, Uzma Iqbal Belgaumi, Arkadeep Dhali, Sameer Dhingra, Ginenus Fekadu, Mahaveer Golechha, Nitin Joseph, Kewal Krishan, Francisco Rogerlāndio Martins-Melo, Sumaira Mubarik, Osaretin Christabel Okonji, Mahesh P. A, Priya Rathi, Ranjitha S. Shetty, Paramdeep Singh, Surjit Singh, Pugazhenthan Thangaraju, Ziyue Wang, Mikhail Sergeevich Zastrozhin, Christopher J.L. Murray, Hmwe Hmwe Kyu, Yangmu Huang |
|
| eClinicalMedicine. 2022; 53: 101646 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Need to ReinvigorateTuberculosis Research in India - A Review of Studies Registered under Clinical Trial Registry of India |
|
|
| Jerin James, Jamuna Rani R, Sathyanarayanan V, Sudha K |
|
| Indian Journal of Tuberculosis. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India |
|
|
| Dinesh Bhurani, Reena Nair, Senthil Rajappa, Suparna Ajit Rao, Nithya Sridharan, Rakesh Reddy Boya, Ganapathi S. Raman, Hari Menon, Arun Seshachalam, Ramesh Nimmagadda |
|
| Frontiers in Oncology. 2022; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India |
|
|
| P.R.E.R.N.A. KHURANA,K.A.R.N.I.K.A. SAIGAL,A.R.N.A.B. GHOSH |
|
| Indian Journal of Tuberculosis. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Progress of South East Asian Region countries towards achieving interim End TB strategy targets for TB incidence and mortality: a modelling study |
|
|
| Y. Krishnamoorthy,R. Nagarajan,S. Rajaa,M.G. Majella,S. Murali,V. Jayaseelan |
|
| Public Health. 2021; 198: 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Excellent synergistic activity of a designed membrane acting pyridinium containing antimicrobial cationic N-acylethanolamine with isoniazid against mycobacterium |
|
|
| Siva Bala Subramaniyan,Megarajan Sengan,Ramesh Subburethinam,Anbazhagan Veerappan |
|
| New Journal of Chemistry. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Rapid detection of Mycobacterium tuberculosis in pus samples of suspected cases of extrapulmonary tuberculosis by GeneXpert MTB/RIF assay and its comparison with conventional methods |
|
|
| Rakesh Kumar, Sweta Muni, Deepak Pankaj, Randhir Kumar, Kumar Saurabh, Shailesh Kumar, Namrata Kumari, ShivendraKumar Shahi |
|
| Journal of Indira Gandhi Institute Of Medical Sciences. 2021; 7(1): 43 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents |
|
|
| K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma |
|
| Research Journal of Pharmacy and Technology. 2021; : 5903 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Atom based 3D QSAR and Fingerprint based 2D QSAR of Novel Molecules as MmpL3 receptor inhibitors for Mycobacterium tuberculosis |
|
|
| Poojita K, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma |
|
| Research Journal of Pharmacy and Technology. 2021; : 6321 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats |
|
|
| Noor Zaheer Ahmed,Hemanth Kumar Agibothu Kupparam,Seema Akbar,Syed Hissar,Noman Anwar,Kannan Thiruvengadam,Nighat Anjum,Asim Ali Khan,Showkat Dar,Saravanan Natarajan |
|
| Journal of Complementary and Integrative Medicine. 2021; 0(0) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Scenario of Tuberculosis in India |
|
|
| Jyoti Priyadarshini Shrivastava, Alok Shrivastava |
|
| Journal of Lung, Pulmonary & Respiratory Research. 2021; 8(2): 24 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Contributing Factors in the Tuberculosis Care Cascade in India: A Systematic Literature Review |
|
|
| Sandul Yasobant,Priya Bhavsar,Pachillu Kalpana,Farjana Memon,Poonam Trivedi,Deepak Saxena |
|
| Risk Management and Healthcare Policy. 2021; Volume 14: 3275 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
TB Free India by 2025: Hype or Hope |
|
|
| Kuldeep Singh Sachdeva |
|
| Expert Review of Respiratory Medicine. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Understanding the gaps in elimination of tuberculosis in India |
|
|
| Khushali Vashi,Yashwant V. Pathak,Jasmin Patel |
|
| Indian Journal of Tuberculosis. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
